Cite

HARVARD Citation

    Montamat-Sicotte, D. et al. (n.d.). 242 Monitoring MDSC – a hurdle to immune checkpoints inhibitors. Journal for immunotherapy of cancer. p. A144. [Online]. 
  
Back to record